Novel Chemical Modalities

The Novel chemical modalities research group is headed by Assistant Professor Sebastian Pomplun. Sebastian started at the division of Medicinal Chemistry within the LACDR in September 2021. His lab develops technologies for the discovery of novel chemical modalities that can address challenging drug targets.

Towards this goal, the group creates innovative drug discovery platforms based on rational design and on combinatorial chemistry to ultimately identify hit compounds targeting therapeutically relevant biomolecules, such as transcription factors or nucleic acids involved in cancer.